These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 8918800

  • 21. Molecular recognition in the bovine immunodeficiency virus Tat peptide-TAR RNA complex.
    Ye X, Kumar RA, Patel DJ.
    Chem Biol; 1995 Dec; 2(12):827-40. PubMed ID: 8807816
    [Abstract] [Full Text] [Related]

  • 22. Molecular basis of HIV-1 TAR RNA specific recognition by an acridine tat-antagonist.
    Gelus N, Hamy F, Bailly C.
    Bioorg Med Chem; 1999 Jun; 7(6):1075-9. PubMed ID: 10428376
    [Abstract] [Full Text] [Related]

  • 23. Refolded HIV-1 tat protein protects both bulge and loop nucleotides in TAR RNA from ribonucleolytic cleavage.
    Harper JW, Logsdon NJ.
    Biochemistry; 1991 Aug 13; 30(32):8060-6. PubMed ID: 1868081
    [Abstract] [Full Text] [Related]

  • 24. Solution structure of the HIV-2 TAR-argininamide complex.
    Brodsky AS, Williamson JR.
    J Mol Biol; 1997 Apr 04; 267(3):624-39. PubMed ID: 9126842
    [Abstract] [Full Text] [Related]

  • 25. NMR evidence for a base triple in the HIV-2 TAR C-G.C+ mutant-argininamide complex.
    Brodsky AS, Erlacher HA, Williamson JR.
    Nucleic Acids Res; 1998 Apr 15; 26(8):1991-5. PubMed ID: 9518494
    [Abstract] [Full Text] [Related]

  • 26. Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro.
    Cordingley MG, LaFemina RL, Callahan PL, Condra JH, Sardana VV, Graham DJ, Nguyen TM, LeGrow K, Gotlib L, Schlabach AJ.
    Proc Natl Acad Sci U S A; 1990 Nov 15; 87(22):8985-9. PubMed ID: 2247474
    [Abstract] [Full Text] [Related]

  • 27. Two distinct nuclear transcription factors recognize loop and bulge residues of the HIV-1 TAR RNA hairpin.
    Sheline CT, Milocco LH, Jones KA.
    Genes Dev; 1991 Dec 15; 5(12B):2508-20. PubMed ID: 1752441
    [Abstract] [Full Text] [Related]

  • 28. Simultaneous recognition of HIV-1 TAR RNA bulge and loop sequences by cyclic peptide mimics of Tat protein.
    Davidson A, Leeper TC, Athanassiou Z, Patora-Komisarska K, Karn J, Robinson JA, Varani G.
    Proc Natl Acad Sci U S A; 2009 Jul 21; 106(29):11931-6. PubMed ID: 19584251
    [Abstract] [Full Text] [Related]

  • 29. Structural mechanism for HIV-1 TAR loop recognition by Tat and the super elongation complex.
    Schulze-Gahmen U, Hurley JH.
    Proc Natl Acad Sci U S A; 2018 Dec 18; 115(51):12973-12978. PubMed ID: 30514815
    [Abstract] [Full Text] [Related]

  • 30. Structure of TAR RNA complexed with a Tat-TAR interaction nanomolar inhibitor that was identified by computational screening.
    Du Z, Lind KE, James TL.
    Chem Biol; 2002 Jun 18; 9(6):707-12. PubMed ID: 12079782
    [Abstract] [Full Text] [Related]

  • 31. Aqueous solution structure of a hybrid lentiviral Tat peptide and a model of its interaction with HIV-1 TAR RNA.
    Mujeeb A, Parslow TG, Yuan YC, James TL.
    J Biomol Struct Dyn; 1996 Feb 18; 13(4):649-60. PubMed ID: 8906885
    [Abstract] [Full Text] [Related]

  • 32. Identification of a novel HIV-1 TAR RNA bulge binding protein.
    Baker B, Muckenthaler M, Vives E, Blanchard A, Braddock M, Nacken W, Kingsman AJ, Kingsman SM.
    Nucleic Acids Res; 1994 Aug 25; 22(16):3365-72. PubMed ID: 8078772
    [Abstract] [Full Text] [Related]

  • 33. Targeting Tat-TAR RNA Interaction for HIV-1 Inhibition.
    Alanazi A, Ivanov A, Kumari N, Lin X, Wang S, Kovalskyy D, Nekhai S.
    Viruses; 2021 Oct 06; 13(10):. PubMed ID: 34696435
    [Abstract] [Full Text] [Related]

  • 34. Identification of ligands for RNA targets via structure-based virtual screening: HIV-1 TAR.
    Filikov AV, Mohan V, Vickers TA, Griffey RH, Cook PD, Abagyan RA, James TL.
    J Comput Aided Mol Des; 2000 Aug 06; 14(6):593-610. PubMed ID: 10921774
    [Abstract] [Full Text] [Related]

  • 35. Monitoring tat peptide binding to TAR RNA by solid-state 31P-19F REDOR NMR.
    Olsen GL, Edwards TE, Deka P, Varani G, Sigurdsson ST, Drobny GP.
    Nucleic Acids Res; 2005 Aug 06; 33(11):3447-54. PubMed ID: 15961729
    [Abstract] [Full Text] [Related]

  • 36. Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA.
    Lind KE, Du Z, Fujinaga K, Peterlin BM, James TL.
    Chem Biol; 2002 Feb 06; 9(2):185-93. PubMed ID: 11880033
    [Abstract] [Full Text] [Related]

  • 37. A functional genetic approach suggests a novel interaction between the human immunodeficiency virus type 1 (HIV-1) Tat protein and HIV-1 TAR RNA in vivo.
    Lund LH, Wahren B, Garcia-Blanco MA.
    J Gen Virol; 2003 Mar 06; 84(Pt 3):603-606. PubMed ID: 12604811
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of HIV-1 replication in viral mutants with altered TAR RNA stem structures.
    Rounseville MP, Lin HC, Agbottah E, Shukla RR, Rabson AB, Kumar A.
    Virology; 1996 Feb 15; 216(2):411-7. PubMed ID: 8607271
    [Abstract] [Full Text] [Related]

  • 39. An ultra-high affinity ligand of HIV-1 TAR reveals the RNA structure recognized by P-TEFb.
    Shortridge MD, Wille PT, Jones AN, Davidson A, Bogdanovic J, Arts E, Karn J, Robinson JA, Varani G.
    Nucleic Acids Res; 2019 Feb 20; 47(3):1523-1531. PubMed ID: 30481318
    [Abstract] [Full Text] [Related]

  • 40. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
    Kundu M, Ansari SA, Chepenik LG, Pomerantz RJ, Khalili K, Rappaport J, Amini S.
    J Hum Virol; 1999 Feb 20; 2(2):72-80. PubMed ID: 10225209
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.